KEYSTONE BIO Trademark

Trademark Overview

On Monday, February 15, 2021, a trademark application was filed for KEYSTONE BIO with the United States Patent and Trademark Office. The USPTO has given the KEYSTONE BIO trademark a serial number of 90529237. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2024. This trademark is owned by Keystone Bio, Inc.. The KEYSTONE BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of neurological and cardiovascular diseases
keystone bio

General Information

Serial Number90529237
Word MarkKEYSTONE BIO
Filing DateMonday, February 15, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of neurological and cardiovascular diseases
NOT AVAILABLE"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKeystone Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63131
Party NameKeystone Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63131

Trademark Events

Event DateEvent Description
Thursday, February 18, 2021NEW APPLICATION ENTERED
Tuesday, May 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 10, 2021ASSIGNED TO EXAMINER
Tuesday, September 14, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 14, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 26, 2021SUSPENSION LETTER WRITTEN
Tuesday, October 26, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, October 26, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 31, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 30, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023SOU EXTENSION 1 FILED
Tuesday, October 17, 2023SOU EXTENSION 1 GRANTED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024SOU EXTENSION 2 GRANTED
Thursday, May 16, 2024SOU EXTENSION 2 FILED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

keystone cardiovascular diseases neurological treatment preparations pharmaceutical